V
VerticalScope Holdings Inc
TSX:FORA
VerticalScope Holdings Inc
TSX:FORA
Price:
2.8
CAD
-3.11%
Market Closed
Market Cap:
CA$60.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
|
VST Tillers Tractors Ltd
NSE:VSTTILLERS
|
IN |
|
Aeon Fantasy Co Ltd
TSE:4343
|
JP |
|
N
|
Nurminen Logistics Oyj
OMXH:NLG1V
|
FI |
|
N
|
N-Able Inc
NYSE:NABL
|
US |
|
Gansu Jingyuan Coal Industry and Electricity Power Co Ltd
SZSE:000552
|
CN |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
W
|
Water Oasis Group Ltd
HKEX:1161
|
HK |
|
Bitterroot Resources Ltd
XTSX:BTT
|
CA |
|
Rimini Street Inc
NASDAQ:RMNI
|
US |
|
MLP Saglik Hizmetleri AS
IST:MPARK.E
|
TR |
|
F
|
FIFAX Abp
OMXH:FIFAX
|
FI |
|
Unum Group
NYSE:UNM
|
US |
|
N
|
Nippon Shinyaku Co Ltd
TSE:4516
|
JP |
|
Shenzhen Increase Technology Co Ltd
SZSE:300713
|
CN |
|
Birla Precision Technologies Ltd
BSE:522105
|
IN |
|
J
|
Johnson & Johnson
DUS:JNJ
|
US |
|
Salter Brothers Emerging Companies Ltd
ASX:SB2
|
AU |
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
KR |
|
Derichebourg SA
PAR:DBG
|
FR |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
APA Corp (US)
NASDAQ:APA
|
US |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
Balance Sheet
Balance Sheet Decomposition
VerticalScope Holdings Inc
VerticalScope Holdings Inc
Balance Sheet Decomposition is not available for
VerticalScope Holdings Inc
VerticalScope Holdings Inc
Balance Sheet
VerticalScope Holdings Inc
VerticalScope Holdings Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
5
|
21
|
9
|
6
|
5
|
16
|
|
| Cash |
5
|
5
|
21
|
9
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
6
|
5
|
16
|
|
| Total Receivables |
13
|
15
|
16
|
16
|
16
|
16
|
16
|
|
| Accounts Receivables |
12
|
14
|
15
|
15
|
13
|
15
|
14
|
|
| Other Receivables |
1
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Other Current Assets |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
18
|
20
|
38
|
26
|
23
|
22
|
33
|
|
| PP&E Net |
5
|
5
|
4
|
3
|
3
|
2
|
1
|
|
| PP&E Gross |
5
|
5
|
4
|
3
|
3
|
2
|
0
|
|
| Accumulated Depreciation |
3
|
3
|
2
|
2
|
2
|
3
|
0
|
|
| Intangible Assets |
47
|
33
|
99
|
71
|
52
|
38
|
26
|
|
| Goodwill |
12
|
12
|
53
|
53
|
53
|
53
|
55
|
|
| Note Receivable |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Long-Term Investments |
3
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
16
|
16
|
21
|
24
|
22
|
18
|
18
|
|
| Other Assets |
12
|
12
|
53
|
53
|
53
|
53
|
55
|
|
| Total Assets |
102
N/A
|
88
-14%
|
217
+147%
|
178
-18%
|
153
-14%
|
132
-13%
|
132
0%
|
|
| Liabilities | ||||||||
| Accounts Payable |
8
|
4
|
10
|
8
|
6
|
7
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
9
|
4
|
4
|
5
|
2
|
1
|
|
| Other Current Liabilities |
1
|
1
|
10
|
16
|
1
|
2
|
1
|
|
| Total Current Liabilities |
18
|
14
|
24
|
29
|
12
|
10
|
12
|
|
| Long-Term Debt |
106
|
96
|
80
|
57
|
57
|
39
|
45
|
|
| Deferred Income Tax |
1
|
0
|
11
|
8
|
4
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
6
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
125
N/A
|
110
-12%
|
121
+10%
|
96
-20%
|
72
-25%
|
50
-31%
|
57
+15%
|
|
| Equity | ||||||||
| Common Stock |
34
|
34
|
160
|
161
|
168
|
163
|
159
|
|
| Retained Earnings |
66
|
67
|
80
|
104
|
109
|
106
|
107
|
|
| Additional Paid In Capital |
8
|
10
|
16
|
25
|
22
|
25
|
23
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
23
N/A
|
23
+2%
|
96
N/A
|
82
-15%
|
81
-1%
|
83
+2%
|
75
-9%
|
|
| Total Liabilities & Equity |
102
N/A
|
88
-14%
|
217
+147%
|
178
-18%
|
153
-14%
|
132
-13%
|
132
0%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
21
|
21
|
21
|
21
|
22
|
21
|
22
|
|
Switch to:
Switch to:
See Also
Discover More
